U.S. markets closed
  • S&P 500

    +100.40 (+2.47%)
  • Dow 30

    +575.77 (+1.76%)
  • Nasdaq

    +390.48 (+3.33%)
  • Russell 2000

    +49.66 (+2.70%)
  • Crude Oil

    +0.98 (+0.86%)
  • Gold

    +3.40 (+0.18%)
  • Silver

    +0.17 (+0.77%)

    +0.0006 (+0.05%)
  • 10-Yr Bond

    -0.0130 (-0.47%)

    +0.0025 (+0.20%)

    -0.0170 (-0.01%)

    +105.06 (+0.36%)
  • CMC Crypto 200

    -3.71 (-0.59%)
  • FTSE 100

    +20.54 (+0.27%)
  • Nikkei 225

    +176.84 (+0.66%)

Loans & Solid Balance Sheet to Aid East West Bancorp (EWBC)

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

East West Bancorp’s EWBC focus on revenue growth through improving loan balances is anticipated to support its financials despite the low interest rates. Further, a strong capital position is likely to help sustain its capital-deployment activities.

East West Bancorp’s organic growth remains impressive. The company’s revenues are largely driven by an improving net interest income (NII), which has witnessed a compound annual growth rate (CAGR) of 5.1% over the last four years (2017-2020). Moreover, its total loans and deposits have witnessed a CAGR of 8.5% and 12.5%, respectively, over the last three years (2018-2020). Given the anticipations of a decent rise in loan demand, the company’s NII is likely to improve further.

East West Bancorp is also focused on maintaining a solid balance sheet. As of Dec 31, 2020, the bank had a total debt of $1.13 billion, and cash and cash equivalents worth $4.02 billion. Given the decent earnings strength and sufficient liquidity, the bank will be able to continue meeting debt obligations, even if the economic situation worsens.

Apart from this, the company’s capital-deployment initiatives look encouraging. East West Bancorp hiked its quarterly dividend by 20% this January, following a 20% hike in April 2019, 15% in July 2018 and 11.1% in January 2015. Further, in March 2020, management authorized a share-repurchase program of up to $500 million worth of shares, of which $354.1 million remained under the buyback plan as of Dec 31, 2020. Thus, given a strong liquidity position, the company will likely be able to sustain efficient capital deployments.

Additionally, over the past six months, shares of East West Bancorp have appreciated 117.7%, outperforming the industry’s 86.1% rally. Moreover, the company’s earnings estimates have shown a favorable trend. The Zacks Consensus Estimate has moved marginally upward for both 2021 and 2022 over the past seven days. Currently, the stock sports a Zacks Rank #1 (Strong Buy).

However, East West Bancorp has been witnessing a contraction in net interest margin (NIM) for the past two years mainly due to lower interest rates. Despite decent loan demand, the NIM might remain under pressure in the near term due to the Fed’s accommodative policy stance.

Other Banks to Consider

Other similarly-ranked finance banks include Ameris Bancorp ABCB, Park National Corporation PRK and Amerant Bancorp Inc. AMTB.

Ameris Bancorp has witnessed an upward earnings estimate revision of 16.4% for the current year, over the past 60 days. Its share price has surged 128.8% over the past six months. You can the complete list of today’s Zacks #1 Rank stocks here.

Park National’s earnings estimate has been revised 11.8% upward for the current year in 60 days’ time. Shares of the company have appreciated 60.6% in the last six months.

Amerant Bancorp has recorded an upward earnings estimate revision of 74.1% for the ongoing year, in the past 60 days. The stock has rallied 83.5% in six months’ time.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

East West Bancorp, Inc. (EWBC) : Free Stock Analysis Report

Ameris Bancorp (ABCB) : Free Stock Analysis Report

Amerant Bancorp Inc. (AMTB) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research